Cardiac Science's "crash cart" defibrillator:
This article was originally published in Clinica
Executive Summary
Cardiac Science has received US FDA 510(k) clearance to market its "crash cart" defibrillator-monitor designed specifically for use by medical professionals responding to cardiac emergencies in hospital settings. The product is lightweight, portable, rugged and easy to use, said the Bothell, Washington firm. It will be sold by GE Healthcare, which has already begun preparations for a worldwide launch. It will be sold in the US and Canada under Cardiac Science's Powerheart brand, and outside North America under GE's Responder brand. Initial shipments of the product are expected to take place during the second quarter of 2006.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.